Information  X 
Enter a valid email address

Antisoma Research Limited (SRC)

  Print      Mail a friend       Annual reports

Thursday 10 March, 2005

Antisoma Research Limited


Antisoma to present at SG Cowen Conference on March 17

10 March 2005, London, UK - Antisoma plc (LSE: ASM) today announces
that Chief Executive Officer, Glyn Edwards, will be presenting at the
25th SG Cowen Annual Healthcare conference, Boston, Mass., USA.

Mr Edwards's presentation is scheduled for 10.30am EST on Thursday,
March 17, with an additional breakout session at 11.20am. A webcast
of the presentation will be available to all on Antisoma's website at

It is recommended that viewers log on 15 minutes early in order to
register and download any necessary software. If you are unable to
participate during the live web cast, a recorded replay of the
presentation will be available for 90 days.


Margherita Lupi
+44 (0)20 8799 8200
Corporate Communications Manager
Antisoma plc

Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products
for the treatment of cancer. Antisoma fills its development pipeline
by acquiring promising new product candidates from internationally
recognised academic or cancer research institutions. Its core
activity is the preclinical and clinical development of these drug
candidates. In November 2002, Antisoma formed a broad strategic
alliance with Roche to develop and commercialise products from
Antisoma's pipeline. Please visit for further